Riskpilot← Back to searchSign inGet full accessClearheart AB
ABActiveOrg 5590695044Rålambsvägen 8 AActivities of holding companies · NACE 6421Est. 20160 employees
Revenue 2025
SEK 0
EBITDA margin
—
+60% vs 2025
Equity ratio
44.1%
Financial strength
Net profit 2025
SEK 1,7M
-11% vs 2025
| Revenue | SEK 0 | — |
| EBITDA | SEK -7K | +60% |
| Net profit | SEK 1,7M | -11% |
| Total assets | SEK 10,3M | +51% |
| Equity | SEK 4,6M | +60% |
| Employees | 0 | — |
Legal name
Clearheart AB
Org number
5590695044
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
6 juli 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva specialistvård med inriktning på hjärt- och kärlsjukdomar och klinisk fysiologi, digital och fysisk hälso- och sjukvård samt utbildning, tjänsteutveckling, processutveckling, systemutveckling, förvaltning och handel av värdepapper och informationsspridning inom nämnda områden och därmed förenlig verksamhet.
Address
Rålambsvägen 8 A
Email
ahmed.daud.ali08@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −19 | −5 | −1 | −17 | −7 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −19 | −5 | −1 | −17 | −7 |
| Net financials | — | — | 881 | 1 938 | 1 721 |
| Profit before tax | −19 | −5 | 879 | 1 920 | 1 714 |
| Tax | — | — | — | — | — |
| Net profit | −19 | −5 | 879 | 1 920 | 1 714 |
| Item | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|
| Total assets | 58 | 53 | 5 230 | 6 848 | 10 341 |
| Equity | 55 | 50 | 929 | 2 849 | 4 563 |
| Long-term debt | — | — | 3 419 | 2 939 | 3 519 |
| Short-term debt | 3 | 3 | 882 | 1 060 | 2 259 |
| Total debt | 3 | 3 | 4 301 | 3 999 | 5 778 |
EBITDA margin
-689300.0%
This company
15.8%
Market median
-4362758% vs market
20222025
Equity ratio
44.1%
This company
38.2%
Market median
+15% vs market
20222025
Return on equity
37.6%
This company
18.4%
Market median
+104% vs market
20222025
Net profit margin
171410300.0%
This company
8.1%
Market median
+2116176443% vs market
20222025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222025
Debt / equity
1.27×
This company
0.62×
Market median
-105% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-06-01 – 2025-12-31
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KF | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Clearheart AB 
Alfa Diagnostik ABBoard members of Clearheart AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Fredrik Hedqvist | Audit | 0 companies |
| Riyan Daud Ali | Deputy Board Member | 0 companies |
| Ahmed Daud Ali | Board of Directors | 0 companies |
| Nema Abdulkadir Salad | Deputy Board Member | 0 companies |